Deciphering the genetic architecture of variation in the immune response to Mycobacterium tuberculosis infection

Proceedings of the National Academy of Sciences of the United States of America

Volumn 109, Issue 4, 2012, Pages 1204-1209

  Barreiro, Luis B ^a,b   Tailleux, Ludovic ^c   Pai, Athma A ^a   Gicquel, Brigitte ^c   Marioni, John C ^a,d   Gilad, Yoav ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b UNIVERSITY OF MONTREAL   (Canada)

^c INSTITUT PASTEUR   (France)

^d WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; DENDRITIC CELL; GENE EXPRESSION; GENE MAPPING; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENETICS; HUMAN; IMMUNE RESPONSE; MALE; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUBERCULOSIS;

ADULT; DENDRITIC CELLS; DUAL-SPECIFICITY PHOSPHATASES; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; MITOGEN-ACTIVATED PROTEIN KINASE PHOSPHATASES; MYCOBACTERIUM TUBERCULOSIS; QUANTITATIVE TRAIT LOCI; TUBERCULOSIS;

MYCOBACTERIUM TUBERCULOSIS;

EID: 84856387609     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1115761109     Document Type: Article

References (49)

1. Hershkovitz I, et al. (2008) Detection and molecular characterization of 9,000-year-old Mycobacterium tuberculosis from a Neolithic settlement in the Eastern Mediterranean. PLoS ONE 3:e3426.
2. Zink AR, et al. (2003) Characterization of Mycobacterium tuberculosis complex DNAs from Egyptian mummies by spoligotyping. J Clin Microbiol 41:359-367. (Pubitemid 36098600)
3. World Health Organization (2009) WHO Report 2009: Global Tuberculosis Control: Epidemiology, Strategy, and Financing (WHO, Geneva).
4. North RJ, Jung YJ (2004) Immunity to tuberculosis. Annu Rev Immunol 22:599-623. (Pubitemid 38680435)
5. Young DB, Gideon HP, Wilkinson RJ (2009) Eliminating latent tuberculosis. Trends Microbiol 17:183-188.
6. Berrington WR, Hawn TR (2007) Mycobacterium tuberculosis, macrophages, and the innate immune response: Does common variation matter? Immunol Rev 219:167-186. (Pubitemid 47390000)
7. Casanova JL, Abel L (2002) Genetic dissection of immunity to mycobacteria: The human model. Annu Rev Immunol 20:581-620.
8. Comstock GW (1978) Tuberculosis in twins: A re-analysis of the Prophit survey. Am Rev Respir Dis 117:621-624.
9. Casanova JL, Abel L (2007) Primary immunodeficiencies: A field in its infancy. Science 317:617-619.
10. Dorman SE, et al. (2004) Clinical features of dominant and recessive interferon gamma receptor 1 deficiencies. Lancet 364:2113-2121. (Pubitemid 39626807)
11. Altare F, et al. (1998) Impairment of mycobacterial immunity in human interleukin-12 receptor deficiency. Science 280:1432-1435. (Pubitemid 28264836)
12. Altare F, et al. (1998) Inherited interleukin 12 deficiency in a child with bacille Calmette-Guérin and Salmonella enteritidis disseminated infection. J Clin Invest 102:2035-2040. (Pubitemid 29018809)
13. Jouanguy E, et al. (1996) Interferon-gamma-receptor deficiency in an infant with fatal bacille Calmette-Guérin infection. N Engl J Med 335:1956-1961.
14. Newport MJ, et al. (1996) A mutation in the interferon-gamma-receptor gene and susceptibility to mycobacterial infection. N Engl J Med 335:1941-1949. (Pubitemid 26428218)
15. de Bakker PI, Telenti A (2010) Infectious diseases not immune to genome-wide association. Nat Genet 42:731-732.
16. Thye T, et al.; African TB Genetics Consortium Wellcome Trust Case Control Consortium (2010) Genome-wide association analyses identifies a susceptibility locus for tuberculosis on chromosome 18q11.2. Nat Genet 42:739-741.
17. Cooper AM (2009) Cell-mediated immune responses in tuberculosis. Annu Rev Immunol 27:393-422.
18. Smyth GK (2004) Linear models and empirical Bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 3:Article3.
19. Huang Q, et al. (2001) The plasticity of dendritic cell responses to pathogens and their components. Science 294:870-875. (Pubitemid 33032108)
20. Tailleux L, et al. (2003) Constrained intracellular survival of Mycobacterium tuberculosis in human dendritic cells. J Immunol 170:1939-1948. (Pubitemid 36197413)
21. Banchereau J, et al. (2000) Immunobiology of dendritic cells. Annu Rev Immunol 18:767-811. (Pubitemid 30365397)
22. Pickrell JK, et al. (2010) Understanding mechanisms underlying human gene expression variation with RNA sequencing. Nature 464:768-772.
23. Stranger BE, et al. (2007) Population genomics of human gene expression. Nat Genet 39:1217-1224. (Pubitemid 47482691)
24. Berry MP, et al. (2010) An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis. Nature 466:973-977.
25. Flynn JL, Chan J (2001) Immunology of tuberculosis. Annu Rev Immunol 19:93-129. (Pubitemid 32368031)
26. Korbel DS, Schneider BE, Schaible UE (2008) Innate immunity in tuberculosis: Myths and truth. Microbes Infect 10:995-1004.
27. Brinckmann J, et al. (2010) Enhanced fibrillin-2 expression is a general feature of wound healing and sclerosis: Potential alteration of cell attachment and storage of TGF-beta. Lab Invest 90:739-752.
28. Ramirez F, Rifkin DB (2009) Extracellular microfibrils: Contextual platforms for TGFbeta and BMP signaling. Curr Opin Cell Biol 21:616-622.
29. Turner M, et al. (1991) Induction of the interleukin 1 receptor antagonist protein by transforming growth factor-beta. Eur J Immunol 21:1635-1639.
30. Muzio M, Sironi M, Polentarutti N, Mantovani A, Colotta F (1994) Induction by transforming growth factor-beta 1 of the interleukin-1 receptor antagonist and of its intracellular form in human polymorphonuclear cells. Eur J Immunol 24:3194-3198.
31. Bellamy R, et al. (1998) Assessment of the interleukin 1 gene cluster and other candidate gene polymorphisms in host susceptibility to tuberculosis. Tuber Lung Dis 79:83-89. (Pubitemid 29078276)
32. Wilkinson RJ, et al. (1999) Influence of polymorphism in the genes for the interleukin (IL)-1 receptor antagonist and IL-1beta on tuberculosis. J Exp Med 189:1863-1874.
33. Maranville JC, et al. (2011) Interactions between glucocorticoid treatment and cisregulatory polymorphisms contribute to cellular response phenotypes. PLoS Genet 7:e1002162.
34. Smirnov DA, Morley M, Shin E, Spielman RS, Cheung VG (2009) Genetic analysis of radiation-induced changes in human gene expression. Nature 459:587-591.
35. Schreiber HA, Sandor M (2010) The role of dendritic cells in mycobacterium-induced granulomas. Immunol Lett 130:26-31.
36. Jiao X, et al. (2002) Dendritic cells are host cells for mycobacteria in vivo that trigger innate and acquired immunity. J Immunol 168:1294-1301. (Pubitemid 34094498)
37. Tian T, Woodworth J, Sköld M, Behar SM (2005) In vivo depletion of CD11c+ cells delays the CD4+ T cell response to Mycobacterium tuberculosis and exacerbates the outcome of infection. J Immunol 175:3268-3272. (Pubitemid 41170548)
38. Wolf AJ, et al. (2007) Mycobacterium tuberculosis infects dendritic cells with high frequency and impairs their function in vivo. J Immunol 179:2509-2519.
39. Bigley V, et al. (2011) The human syndrome of dendritic cell, monocyte, B and NK lymphoid deficiency. J Exp Med 208:227-234.
40. Hambleton S, et al. (2011) IRF8 mutations and human dendritic-cell immunodeficiency. N Engl J Med 365:127-138.
41. Sturgill-Koszycki S, et al. (1994) Lack of acidification in Mycobacterium phagosomes produced by exclusion of the vesicular proton-ATPase. Science 263:678-681.
42. Armstrong JA, Hart PD (1975) Phagosome-lysosome interactions in cultured macrophages infected with virulent tubercle bacilli. Reversal of the usual nonfusion pattern and observations on bacterial survival. J Exp Med 142:1-16.
43. Salojin K, Oravecz T (2007) Regulation of innate immunity by MAPK dual-specificity phosphatases: Knockoutmodels reveal new tricks of old genes. J Leukoc Biol 81:860-869. (Pubitemid 46495635)
44. Brooks MN, et al. (2011) NOD2 controls the nature of the inflammatory response and subsequent fate of Mycobacterium tuberculosis and M. bovis BCG in human macrophages. Cell Microbiol 13:402-418.
45. Divangahi M, et al. (2008) NOD2-deficient mice have impaired resistance to Mycobacterium tuberculosis infection through defective innate and adaptive immunity. J Immunol 181:7157-7165.
46. Pandey AK, et al. (2009) NOD2, RIP2 and IRF5 play a critical role in the type I interferon response to Mycobacterium tuberculosis. PLoS Pathog 5:e1000500.
47. Smith AN, et al. (2003) Revised nomenclature for mammalian vacuolar-type H+ -ATPase subunit genes. Mol Cell 12:801-803. (Pubitemid 37352774)
48. Xu S, et al. (1994) Intracellular trafficking in Mycobacterium tuberculosis and Mycobacterium avium-infected macrophages. J Immunol 153:2568-2578. (Pubitemid 24278126)
49. Backes C, et al. (2007) GeneTrail - advanced gene set enrichment analysis. Nucleic Acids Res 35:W186-192.